RxDoctor Payments Data

Beatrisa Paz Averbuch, MD

Family Medicine · Skokie, ILNPI 1669638979

Payments from drug & device makers

$749in general payments, 2019–2025

Across 36 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$157
  • AbbVie$111
  • Sunovion Pharmaceuticals Inc.$109
  • Galderma Laboratories, L.p.$101
  • Astellas Pharma US Inc$45
  • Novo Nordisk$44
  • plus $182 from 8 others

What the payments were for

  • Food & beverage$71796%
  • Education$324%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$749 in reported general payments places this provider in the 70th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$480,357
Medicare patients
574
Services billed
5,899

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban362$169,620
LinzessLinaclotide114$70,538
OzempicSemaglutide64$67,505
FarxigaDapagliflozin Propanediol75$62,951
TrulicityDulaglutide42$49,157
MounjaroTirzepatide43$48,283
XareltoRivaroxaban113$47,176
JardianceEmpagliflozin44$37,195
CreonLipase/Protease/Amylase44$34,058
MyrbetriqMirabegron93$32,841
JanuviaSitagliptin Phosphate58$29,258
TradjentaLinagliptin45$21,154
WegovySemaglutide13$20,471
ProliaDenosumab11$19,564
EntrestoSacubitril/Valsartan35$19,063

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon, Namzaric, Synthroid$111$120,692275 claims
Novo NordiskOzempic, Wegovy$44$87,97677 claims
Johnson & JohnsonXarelto, Invokana$157$63,099128 claims
AstraZenecaFarxiga$16$62,95175 claims
Astellas Pharma US IncMyrbetriq$45$32,84193 claims
MerckJanuvia$20$29,25858 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Skokie

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →